Process For Appealing FDA Actions To Be Clarified, CDRH Ombudsman Says
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is reworking procedures for resolving disputes between industry and FDA reviewers, and expanding the types of regulatory actions that can be appealed.